Next Article in Journal
Optional Vaccines in Children—Knowledge, Attitudes, and Practices in Romanian Parents
Next Article in Special Issue
Pivotal Shigella Vaccine Efficacy Trials—Study Design Considerations from a Shigella Vaccine Trial Design Working Group
Previous Article in Journal
HLA Class II Polymorphism and Humoral Immunity Induced by the SARS-CoV-2 mRNA-1273 Vaccine
Previous Article in Special Issue
Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial
 
 
Review

Article Versions Notes

Vaccines 2022, 10(3), 403; https://doi.org/10.3390/vaccines10030403
Action Date Notes Link
article xml file uploaded 7 March 2022 11:15 CET Original file -
article xml uploaded. 7 March 2022 11:15 CET Update https://www.mdpi.com/2076-393X/10/3/403/xml
article pdf uploaded. 7 March 2022 11:15 CET Version of Record https://www.mdpi.com/2076-393X/10/3/403/pdf
article html file updated 7 March 2022 11:16 CET Original file -
article html file updated 1 August 2022 04:26 CEST Update https://www.mdpi.com/2076-393X/10/3/403/html
Back to TopTop